PMH21 COST-EFFECTIVENESS-ANALYSIS OF RISPERIDONE LONG-ACTING INJECTION IN SCHIZOPHRENIA- 12 MONTH DATA FROM CZECH REPUBLIC
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66921-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)66921-5/fulltext
Section Title :
Section Order :
754
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66921-5&doi=10.1016/S1098-3015(10)66921-5